Health Canada
- Status: approved
🇨🇦 Non-nucleoside reverse transcriptase inhibitor in Canada
Non-nucleoside reverse transcriptase inhibitor (Non-nucleoside reverse transcriptase inhibitor) regulatory status in Canada.
Marketing authorisation
Non-nucleoside reverse transcriptase inhibitor in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Non-nucleoside reverse transcriptase inhibitor approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Non-nucleoside reverse transcriptase inhibitor in Canada?
GlaxoSmithKline is the originator. The local marketing authorisation holder may differ — check the official source linked above.